[HTML][HTML] Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated …

S Mirza, G Sharma, R Parshad… - Journal of breast …, 2013 - synapse.koreamed.org
Purpose The DNA methylation mediated by specific DNA methyltransferases (DNMTs),
results in the epigenetic silencing of multiple genes which are implicated in human breast …

Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas

I Girault, S Tozlu, R Lidereau, I Bieche - Clinical cancer research, 2003 - AACR
Purpose: Three genes, namely DNA methyltransferase (DNMT) 1, DNMT3A, and DNMT3B,
coding for DNMTs that affect promoter methylation status are thought to play an important …

DNA methyltransferase 1/3a overexpression in sporadic breast cancer is associated with reduced expression of estrogen receptor‐alpha/breast cancer susceptibility …

Z Yu, Q Xiao, L Zhao, J Ren, X Bai, M Sun… - Molecular …, 2015 - Wiley Online Library
DNA methyltransferases (DNMTs), including DNMT1, 3a, and 3b, play an important role in
the progression of many malignant tumors. However, it remains unclear whether expression …

Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer

T Fujikane, N Nishikawa, M Toyota, H Suzuki… - Breast cancer research …, 2010 - Springer
Breast cancer arises through the accumulation of multiple genetic alterations and epigenetic
changes such as methylation, which silences gene expression in a variety of cancers. In the …

[HTML][HTML] DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines

JD Roll, AG Rivenbark, WD Jones, WB Coleman - Molecular cancer, 2008 - Springer
Background DNA hypermethylation events and other epimutations occur in many
neoplasms, producing gene expression changes that contribute to neoplastic …

[HTML][HTML] Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors

M Hegde, MB Joshi - Journal of Cancer Research and Clinical Oncology, 2021 - Springer
Significant reprogramming of epigenome is widely described during pathogenesis of breast
cancer. Transformation of normal cell to hyperplastic cell and to neoplastic phenotype is …

[HTML][HTML] DNA methyltransferases: a novel target for prevention and therapy

D Subramaniam, R Thombre, A Dhar, S Anant - Frontiers in oncology, 2014 - frontiersin.org
Cancer is the second leading cause of death in US. Despite the emergence of new, targeted
agents, and the use of various therapeutic combinations, none of the available treatment …

[HTML][HTML] DNMT3A and DNMT3B in breast tumorigenesis and potential therapy

X Man, Q Li, B Wang, H Zhang, S Zhang… - Frontiers in cell and …, 2022 - frontiersin.org
Breast cancer has become a leading cause of cancer-related deaths in women worldwide.
DNA methylation has been revealed to play an enormously important role in the …

DNA methylation and breast carcinogenesis

M Widschwendter, PA Jones - Oncogene, 2002 - nature.com
Abstract Knowledge about breast carcinogenesis has accumulated during the last decades
but has barely been translated into strategies for early detection or prevention of this …

Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors

F Chik, M Szyf - Carcinogenesis, 2011 - academic.oup.com
A hallmark of cancer is aberrant DNA methylation, consisting of global hypomethylation and
regional hypermethylation of tumor suppressor genes. DNA methyltransferase inhibitors …